학술논문
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE‐SPECT ESUS Trial
Document Type
article
Author
Del Brutto, Victor J; Diener, Han‐Christoph; Easton, J Donald; Granger, Christopher B; Cronin, Lisa; Kleine, Eva; Grauer, Claudia; Brueckmann, Martina; Toyoda, Kazunori; Schellinger, Peter D; Lyrer, Philippe; Molina, Carlos A; Chutinet, Aurauma; Bladin, Christopher F; Estol, Conrado J; Sacco, Ralph L
Source
Journal of the American Heart Association. 11(11)
Subject
Language
Abstract
Background We sought to determine recurrent stroke predictors among patients with embolic strokes of undetermined source (ESUS). Methods and Results We applied Cox proportional hazards models to identify clinical features associated with recurrent stroke among participants enrolled in RE-SPECT ESUS (Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate Versus Acetylsalicylic Acid in Patients With Embolic Stroke of Undetermined Source) trial, an international clinical trial evaluating dabigatran versus aspirin for patients with ESUS. During a median follow-up of 19 months, 384 of 5390 participants had recurrent stroke (annual rate, 4.5%). Multivariable models revealed that stroke or transient ischemic attack before the index event (hazard ratio [HR], 2.27 [95% CI, 1.83-2.82]), creatinine clearance